22nd Century Group Inc is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The company manufactures and distributes the only combustible tobacco products containing minimally or non-addictive levels of nicotine. The Company has organized its business as a single reportable segment: tobacco, as it operates and derives all revenues from its tobacco operations and products.
Last trade$0.4332
Day change-$0.06 (-12.17%)
Day range$0.422 – $0.486
Volume1,363,108
Market cap$0M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$269.92K
Price / earnings
—
Price / book
0.01×
Price / sales
0.02×
EV / sales
-0.33×
EV / EBITDA
0.42×
Profitability
Earnings per share
-$62.68
Return on assets
-131.95%
Return on equity
-185.21%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.06×
Current ratio
2.61×
Quick ratio
1.9×
Cash ratio
0.94×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$8.75M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for XXII, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Revenue
$2.86M
$4.11M
$3.54M
$4.01M
$4.08M
$5.96M
$4.02M
$5.95M
Cost of revenue
$1.62M
$4.74M
-$6.17M
$5.07M
$2.86M
$6.57M
-$7.23M
$6.53M
Gross profit
$1.24M
-$636K
$9.7M
-$1.06M
$1.22M
-$609K
$11.25M
-$588K
Selling, general and administrative
$2.7M
$2.12M
$1.83M
$1.85M
$2.12M
$1.8M
$2.47M
$2.55M
Research and development
$295K
$285K
$105K
$193K
$227K
$162K
$218K
$240K
Total operating expenses
$4.53M
$2.4M
$12.47M
$2.04M
$4.2M
$1.96M
$15.2M
$2.79M
Operating income
-$3.29M
-$3.04M
-$2.76M
-$3.1M
-$2.98M
-$2.57M
-$3.94M
-$3.38M
Interest expense
-$17K
-$11K
-$12K
-$534K
-$351K
-$558K
-$266K
-$311K
Income before taxes
-$3.27M
-$3.02M
-$2.78M
-$3.76M
-$3.33M
-$3.27M
-$4.24M
-$3.59M
Income taxes
$0
$0
$6K
$0
-$34K
$0
$3K
$0
Net income
-$3.35M
-$3.26M
-$2.81M
$5.49M
-$3.41M
-$4.33M
-$4.56M
-$3.76M
Net income attributable to common shareholders
-$21.76M
-$10.77M
-$7.49M
$5.49M
-$3.41M
-$4.33M
-$7.15M
-$7.43M
EBITDA
-$3.08M
-$2.83M
-$2.55M
-$2.87M
-$2.75M
-$2.35M
-$3.7M
-$3.13M
Basic earnings per share
-$6,032.00
-$20,972.80
-$18,287.24
$26,970.00
-$196,622.90
-$972,578.80
—
-$30,628,524.00
Diluted earnings per share
-$6,032.00
-$20,972.80
—
-$4,872.00
-$196,622.90
-$972,578.80
—
-$30,628,524.00
Recent news
Company coverage with links to the original publishers.
With U.S. crude above $100 per barrel, investors are turning to smaller companies with emerging technologies. Kraig Biocraft Laboratories shipped its first commercial spider silk order, Hyperscale Data reaffirmed 2027 revenue guidance of $300-350 million, Lucid Diagnostics began receiving Medicare payments for its EsoGuard test, and 22nd Century Group reported 66% quarterly revenue growth with improving profitability metrics.
22nd Century Group reported Q1 2026 net revenues of $4.1 million with a net loss of $3.3 million. The company announced plans to expand VLN® cigarette distribution to over 5,000 retail outlets by end of 2026, with products now available in over 2,000 stores across 20 states. The company maintains zero long-term debt and $9.5 million in cash, while advancing multiple PMTA applications for expanded product categories including 100mm cigarettes and filtered cigars.
22nd Century Group announced Q4 2025 results showing net revenues of $3.5M (down from $4.0M in Q3) and a net loss of $2.8M. The company reported achieving a debt-free balance sheet with $7.1M in cash and a $9.5M insurance settlement from the 2022 facility fire. The company is executing a strategic shift toward higher-margin branded VLN® products, expanding retail distribution across convenience store chains, and increasing state authorizations for its reduced-nicotine cigarette products.
22nd Century Group received a $9.5 million insurance settlement for business interruption claims, causing its stock to surge 39% in after-hours trading. The company is focusing on its VLN reduced-nicotine cigarette product line and preparing for its Q3 earnings report.
22nd Century Group settled a business interruption insurance claim for $9.5 million, becoming debt-free and positioning itself to drive towards profitability in 2026 by focusing on its low-nicotine VLN® cigarette product.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.